Double Medical Technology Inc. (002901.SZ)
CNY 32.76
(-1.71%)
CNY 32.76
(-1.71%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -627.64 Million CNY | 32.08% |
| 2022 | -924.09 Million CNY | -136.01% |
| 2021 | -391.54 Million CNY | 26.22% |
| 2020 | -530.69 Million CNY | 27.29% |
| 2019 | -729.84 Million CNY | 8.79% |
| 2018 | -800.15 Million CNY | -57.4% |
| 2017 | -508.37 Million CNY | -712.14% |
| 2016 | -62.59 Million CNY | -73.74% |
| 2015 | -36.02 Million CNY | 55.59% |
| 2014 | -81.13 Million CNY | -119.71% |
| 2013 | -36.92 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -648.2 Million CNY | -10.86% |
| 2024 Q1 | -407.9 Million CNY | 35.01% |
| 2024 Q2 | -584.69 Million CNY | -43.34% |
| 2023 Q2 | -693.97 Million CNY | 6.22% |
| 2023 FY | -627.64 Million CNY | 32.08% |
| 2023 Q4 | -627.64 Million CNY | -4.99% |
| 2023 Q3 | -597.79 Million CNY | 13.86% |
| 2023 Q1 | -739.97 Million CNY | 19.92% |
| 2022 Q2 | -716.49 Million CNY | -2.91% |
| 2022 Q1 | -696.21 Million CNY | -77.81% |
| 2022 FY | -924.09 Million CNY | -136.01% |
| 2022 Q4 | -924.09 Million CNY | -60.75% |
| 2022 Q3 | -574.88 Million CNY | 19.76% |
| 2021 Q2 | -373.85 Million CNY | 38.01% |
| 2021 Q3 | -347.82 Million CNY | 6.96% |
| 2021 Q4 | -391.54 Million CNY | -12.57% |
| 2021 Q1 | -603.07 Million CNY | -8.7% |
| 2021 FY | -391.54 Million CNY | 26.22% |
| 2020 Q4 | -554.82 Million CNY | 6.05% |
| 2020 FY | -530.69 Million CNY | 27.29% |
| 2020 Q1 | -783.73 Million CNY | -2.51% |
| 2020 Q2 | -570.43 Million CNY | 27.22% |
| 2020 Q3 | -590.53 Million CNY | -3.52% |
| 2019 FY | -729.84 Million CNY | 8.79% |
| 2019 Q4 | -764.57 Million CNY | -5.96% |
| 2019 Q3 | -721.57 Million CNY | 3.23% |
| 2019 Q2 | -745.61 Million CNY | 5.81% |
| 2019 Q1 | -791.65 Million CNY | 4.37% |
| 2018 Q2 | -727.66 Million CNY | -37.82% |
| 2018 FY | -800.15 Million CNY | -57.4% |
| 2018 Q4 | -827.86 Million CNY | -10.57% |
| 2018 Q3 | -748.71 Million CNY | -2.89% |
| 2018 Q1 | -527.98 Million CNY | -3.86% |
| 2017 Q4 | -508.37 Million CNY | 9.23% |
| 2017 FY | -508.37 Million CNY | -712.14% |
| 2017 Q1 | 228.09 Million CNY | 464.39% |
| 2017 Q2 | -92.24 Million CNY | -140.44% |
| 2017 Q3 | -560.07 Million CNY | -507.15% |
| 2016 FY | -62.59 Million CNY | -73.74% |
| 2016 Q4 | -62.59 Million CNY | 0.0% |
| 2015 FY | -36.02 Million CNY | 55.59% |
| 2014 FY | -81.13 Million CNY | -119.71% |
| 2013 FY | -36.92 Million CNY | 0.0% |